Ziath reports how its 2ml CryzoTraq™ 2-ECT storage tube maintains high sample integrity by minimising the chance of cross-contamination as their externally threaded design eliminates the possibility of sample encountering the screw thread.
Author Archive for: panglobal
This author has yet to write their bio.
Entries by panglobal
Biotech Fluidics has published a practical review paper that demonstrates how its MarvelX™ and MarvelXACT™ high pressure fluidic connections enable users to achieve reliable, repeatable, and consistent UHPLC performance. In this paper, fluidic experts explore the connection challenges facing users of modern UHPLC instruments.
They are found in humans and many animal species. Tecan’s new product, Steroid Panel Tec-TraceTM, is intended to be used as an aid in the analysis of 17 steroid hormones and dexamethasone, particularly using LC-MS methods.
DAS an experienced Medical Laboratory Automation Designer and Manufacturer, with its highly skilled engineers, is committed to constantly develop and enhance the performances of its lab processors. Within the full automation product range there are instruments to process: ELISA microplates, IFA immunofluorescence-slides and BLOT line strips, the named technologies can be also processed at same […]
AntlerA Norrin/Wnt-agonist antibody, through a strategic partnership with EyeBio, has entered clinical trials for treatment of retinopathies.
Genomic Vision, a Euronext-listed biotechnology company that develops products and services for the characterization of DNA sequences, has secured an exclusive European distribution agreement with CliniSciences.
GBA Group, a leading European life science service provider, has entered the U.S. market with a site in Westborough, Massachusetts to support clinical trials. Located in the greater Boston area, a pharmaceutical and biotech hub, the laboratory and logistics site will be fully operational in October this year and will offer a broad range of […]
Appointment part of company’s ambitious global growth strategy
Avacta Group has acquired Coris Bioconcept for £7.4 million and an extra £3 million payout based on future business performance.
Integrative solutions at the speed of life